Always Pure Organics creating a retail-ready range of CBD brands to allow businesses immediate, fuss-free integration into the competitive CBD marketplace.
The CBD industry is unique in its potential, experiencing rapid growth -with the global CBD market is estimated to reach $20+ billion by 2024 – the implementation of regulations is racing to keep up. The UK is the first proactively regulated market for CBD and this helps to support the legitimising of the CBD industry.
For many businesses dipping their toe into the CBD industry for the first time, navigating the evolving regulations, geographically and locally, as well as the potential upfront cost of white labelling, without a guarantee of sales can be daunting.
By creating four excellent quality, FSA compliant (as part of a wider UK Novel Foods application) and highly traceable fully regulated brands, Always Pure Organics allows businesses the option for immediate, fuss-free integration into the competitive CBD marketplace. Designed to work as a supplement to, or the first step towards white labelling, the Retail Ready brands cover a broad spectrum of consumer needs and are highly targeted towards different markets. They are all available at low minimum order levels, to ensure maximum flexibility in a highly competitive marketplace.
Each individual Retail Ready brand is developed and produced using the finest ingredients and undergo strict controls to ensure purity, potency and consistency. All product ranges have maximum traceability; all can be accounted for, at every step of the process, from raw ingredients to the finished article. In addition, all our Retail Ready brands are fully compliant, with all foodstuffs and food supplements submitted to the FSA as part of our wider UK Novel Foods application.
Andrew Megahy, chief scientific officer at Always Pure Organics discusses this commitment to removing uncertainty for businesses:
“Always Pure Organics is a wholesale manufacturer and distributor of specialist cannabis-based products. With a
portfolio covering items such as bespoke cosmetics, flavoured gummies and unique terpene-blended CBD oils, our in-house formulation team have the experience and creativity to take on new – and improve existing -projects.
We are committed to providing only the highest quality products and ensure everything we do is fully legal – removing any uncertainty that working in the cannabis industry can often bring.”
The brands that sit in the Retail Ready portfolio are targeted towards different markets, allowing clients to choose the ranges that best suit their business needs. From entry-level to premium, from traditional, artisan-style products to those that sit comfortably in spas and treatment rooms, there is a solution to meet all business needs.
Always Pure Organic brands
Vitae CBD: restoring your natural balance
Vitae CBD brand from Always Pure Organics offers a blend of nature and science by infusing a collection of luxurious balms, lotions and oils that release the full potential of the hemp plant, which has been used for health and wellbeing for thousands of years. We use only the highest quality, organically grown, pesticide-free raw materials in order to restore natural balance and keep skin feeling restored and enriched.
Apothecary Collection: indulgence on your terms, in your time
The Apothecary Collection enables indulgence on your terms, a spa experience from the comfort of your own home. The Apothecary Collection combines the finest quality CBD with a cornucopia of delicious flavours, fragrances and active ingredients, all artfully blended to help boost a healthy mind and body.
Bao Botanicals: supported by science, rooted in nature
The Bao Botanicals CBD face and body range is developed to carefully combine a host of key benefits, aimed at
strengthening and repairing the skin’s natural barrier, reducing inflammation and creating a healthy, natural glow.
From enriching CBD balms and uplifting oils to our soothing tattoo cream, Bao Botanicals is crafted with the consumer
Essential Collection: fuss-free CBD
The Always Pure Organics Essential Collection offers the ideal range of CBD products for those at the start of their CBD journey. Our
accessibly-priced range of oils, capsules and gummies gives those new to CBD the flexibility to experiment and find the type and strength that suits them best. Exceptional quality at a modest price.
To learn more about how Always Pure Organics Retail Ready can support immediate, fuss-free integration into the competitive CBD marketplace for your business, or for any other questions or information on CBD, get in touch today
95% of patients with rare skin condition report improvements with cannabis topicals
Epidermolysis Bullosa causes severe blistering which can become infected after any trauma or friction.
A new study of a rare skin condition has revealed that different preparations of cannabinoids could have benefits for patients with painful Epidermolysis Bullosa (EB).
Epidermolysis Bullosa (EB) is the name of a group of rare inherited skin disorders that can cause the skin to become fragile.
It is thought to be caused by a gene mutation that makes the skin more fragile and any trauma or friction can cause painful blisters on the skin. There is currently no cure but treatment aims to prevent infection and reduce symptoms.
The study from the Netherlands and the United States analysed EB patients on five different continents who reported using cannabis preparations as a treatment for their rare skin condition.
The data is published in the Orphanet Journal of Rare Diseases. The patients reported using topical cannabinoid products in addition to inhaling cannabis flowers. They also consumed cannabis-infused edibles.
Patients were given a survey on their skin condition that focused on monitoring effects including perceived EB symptom changes, medication use, and side effects.
Skin condition results
Results recorded that 95 percent said the topicals improved their overall skin condition symptoms with 94 percent stating their pain levels were decreased.
A further 91 percent said they had less itching and 81 reported wound healing was improved. Most of the participants at 79 percent said they had decreased their medication for their skin condition. The only side effect with a notable significance was dry mouth at 44 percent.
The authors noted that cannabis improved patient’s “perception of pain, pruritus, wound-healing, and well-being … and reduced concomitant medication use.”
They wrote that: “Future prospective controlled clinical studies are warranted to elucidate the potential role of CBMs (cannabis-based medicines) in EB treatment.”
Study: Could CBD help with alopecia?
A new study on topical CBD finds it may be as effective as other treatments on the market but further testing is needed
A new study on alopecia revealed that topical CBD use over time may help with regrowth. It could offer an alternative, non-invasive treatment for the condition.
Androgenetic alopecia can sometimes be referred to as female or male pattern baldness. It can cause thin or bald patches across the head. There are different forms of alopecia such as alopecia areata that can cause hair to fall out in patches, these may connect becoming noticeable. It develops when the immune system attacks the hair follicles. It may also affect eyebrows, eyelashes and face while developing over time.
The researchers stated that the endocannabinoid system (ECS) may be involved in maintaining cellular homeostasis by regulating inflammatory response and regenerative progress.
The endocannabinoid system has three core components: endocannabinoids, receptors and enzymes. These receptors can be found throughout the body. Endocannabinoids bind to them to send signals that the system needs to be active and do something. The main two receptors are CB1 which is found in the central nervous system and CB2 in the peripheral nervous system. Cannabinoids are thought to bind or influence these receptors.
All of these receptors relate to hair follicle function. Researchers examined if blocking the CB1 receptor on the hair follicle with CBD could have a result in hair shaft elongation. They noted that the effects are dose-dependent and higher doses may have a different effect.
This study was conducted to determine if daily topical application of hemp oil high in CBD concentration would result in significant hair regrowth in the area of the scalp most affected by androgenetic alopecia (AGA)
The study took 35 participants with AGA and gave them a once-daily topical dose of CBD. This was on average 3 to 4 mg per day for six months. The researchers conducted a hair count of the greatest areas of alopecia before treatment and after six months. To facilitate this, a clear acrylic mould with a cut out was made of each person’s head.
When it came to results, the men reported more regrowth than women and the vertex area did better than the temporal ones. vertex transition point refers to the area where the scalp goes from a horizontal to vertical while the temporal areas. There was an increased average of 95 percent in non-vellus hair after six months of daily use. All subjects reported some regrowth with no adverse effects.
The researchers felt that the CBD treatment offered comparable effects to other treatments on the market and could be used alongside them to maximise the effects. However, they stressed this combination would need further testing.
The authors wrote: “Topical CBD formulation has comparable results to finasteride and comparable results to 5% minoxidil once daily foam. Since the CBD works through novel mechanisms different from finasteride and minoxidil, it can be used in conjunction with these current drugs and would be expected to have synergistic effects.”
New Gen-Z CBD beauty brand launches with 1.7 million views on TikTok
The new brand, Love MeMeMe aim to encourage people to take time out for self-care.
A new CBD brand, Love MeMeMe has hit 1.7 million views on TikTok by sharing their hashtag, #metheloveofmyownlife.
The brand offers a range of gender-neutral, self-care CBD beauty items including lip balms, hair masks and body butter. The brand is aimed at Gen-Z consumers rather than millennials or baby boomers.
As part of a marketing campaign, Love MeMeMe partnered with TikTok influencers to launch the products. Liana Jade, Miah Carter, Max Ragan, Chloe Rose, Bobbie, Elvira Styles and Hani Hans endorsed the brand on the platform. Each one of the influencers explained what self-love means to them and what their self-love tips are.
The range combines not just CBD but active ingredients such as retinol and Vitamin A and E. The bright colourful packaging is not only eye-catching but the price point is easily accessible with products starting at £8. There are nine products in the collection which launched this week.
Gen-Z consumers who are described as those born between 1997 and 2012. This explains the TikTok focus, it is estimated that by the end of this year, there will be more Gen-Z users on TikTok than on Instagram with 37.3 million Gen Z users. Although Snapchat is one of the biggest platforms amongst this age group, it is thought that the brand will overtake it by 2023.
It’s working for Love MeMeMe who have gained 1.7 million views on the platform in just under a week.
Gen-Z CBD use
These aren’t unusual figures for Gen-Z who are described as the first wave of truly digital native consumers. They aren’t just used to consistent connectivity but also, CBD and cannabis consumption is becoming normalised.
In the US, a recent study from a Seattle-based cannabis data brand, Headset revealed that Gen-Z is the fastest-growing segment of the cannabis industry. In the past year, sales to Gen-Z surged by 127 percent with the biggest percentage among females. This is an even bigger amount when compared to sale increases among other generations. Millennial sales increased by 46 percent, Gen X increased by 29 percent and baby boomers by 5 percent.
Headset noted: “This demographic will continue to drive exponential growth, so it’s important to pay attention and understand their preferences.”
The same study also showed that Gen-Z prefers to smoke cannabis with only 10 percent spending money on other ways to consume CBD. This is down from 15 percent for other generations. They are also less brand loyal as well with only 20.6 percent preferring to stick to one brand.
Introducing our new B2B title
- Is it time for a T (tolerance)-break?
- 95% of patients with rare skin condition report improvements with cannabis topicals
- How do I access a medical cannabis prescription?
- Patient Voices: “I feel like I can plan for the future instead of having to take one day at a time”
- How The Good Level is changing the UK CBD market for the better
- Cannabis legalisation not linked to rise in car accidents, says study
News10 months ago
Community extends support to cannabis icon Rick Simpson
News1 year ago
NHS lines up cannabis medicine manufacturing
Case Studies2 years ago
CBD oil and fibromyalgia – a case study
News12 months ago
Cancer survivor claims cannabis oil helped her beat brain tumour
Insight11 months ago
I’ve gone from a wheelchair to walking thanks to cannabis
News9 months ago
UK grants second licence to grow high-THC medical cannabis
Feature1 year ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt
Industry8 months ago
“Game changer” for the sector: First cannabis company expected to list on LSE next month